• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国荨麻疹的流行病学:一项基于人群的研究。

Epidemiology of urticaria in China: a population-based study.

机构信息

Department of Dermatology, Peking University People's Hospital, Beijing 100044, China.

Department of Dermatology, Beijing Children's Hospital, Capital Medical University, Beijing 100045, China.

出版信息

Chin Med J (Engl). 2022 Jun 5;135(11):1369-1375. doi: 10.1097/CM9.0000000000002172.

DOI:10.1097/CM9.0000000000002172
PMID:35830258
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9433071/
Abstract

BACKGROUND

Urticaria is a common skin disease characterized by episodes of wheals, and it has a negative effect on patients' quality of life. Large-scale population-based epidemiological studies of urticaria are scarce in China. The aim of this survey was to determine the prevalence, clinical forms, and risk factors of urticaria in the Chinese population.

METHODS

This survey was conducted in 35 cities from 31 provinces, autonomous regions, and municipalities of China. Two to three communities in each city were selected in this investigation. Participants completed questionnaires and received dermatological examinations. We analyzed the prevalence, clinical forms, and risk factors of urticaria.

RESULTS

In total, 44,875 questionnaires were distributed and 41,041 valid questionnaires were collected (17,563 male and 23,478 female participants). The lifetime prevalence of urticaria was 7.30%, with 8.26% in female and 6.34% in male individuals ( P  < 0.05). The point prevalence of urticaria was 0.75%, with 0.79% in female and 0.71% in male individuals ( P  < 0.05). Concomitant angioedema was found in 6.16% of patients. Adults had a higher prevalence of urticaria than adolescents and children. Living in urban areas, exposure to pollutants, an anxious or depressed psychological status, a personal and family history of allergy, thyroid diseases, and Helicobacter pylori infection were associated with a higher prevalence of urticaria. Smoking was correlated with a reduced risk of urticaria.

CONCLUSION

This study demonstrated that the lifetime prevalence of urticaria was 7.30% and the point prevalence was 0.75% in the Chinese population; women had a higher prevalence of urticaria than men. Various factors were correlated with urticaria.

摘要

背景

荨麻疹是一种常见的皮肤病,其特征为反复发作的风团,对患者的生活质量有负面影响。中国缺乏大规模的基于人群的荨麻疹流行病学研究。本研究旨在确定中国人群中荨麻疹的患病率、临床类型和危险因素。

方法

本研究在中国 31 个省、自治区和直辖市的 35 个城市进行。在每个城市选择 2-3 个社区。参与者完成问卷并接受皮肤科检查。我们分析了荨麻疹的患病率、临床类型和危险因素。

结果

共发放 44875 份问卷,回收有效问卷 41041 份(男性 17563 例,女性 23478 例)。荨麻疹的终身患病率为 7.30%,女性为 8.26%,男性为 6.34%(P<0.05)。荨麻疹的时点患病率为 0.75%,女性为 0.79%,男性为 0.71%(P<0.05)。同时伴有血管性水肿的患者占 6.16%。成人的荨麻疹患病率高于青少年和儿童。居住在城市、接触污染物、焦虑或抑郁心理状态、个人和家族过敏史、甲状腺疾病和幽门螺杆菌感染与荨麻疹的高患病率相关。吸烟与荨麻疹的低患病风险相关。

结论

本研究表明,中国人群的荨麻疹终身患病率为 7.30%,时点患病率为 0.75%;女性的患病率高于男性。各种因素与荨麻疹相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3148/9433071/84473db6bece/cm9-135-1369-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3148/9433071/84473db6bece/cm9-135-1369-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3148/9433071/84473db6bece/cm9-135-1369-g001.jpg

相似文献

1
Epidemiology of urticaria in China: a population-based study.中国荨麻疹的流行病学:一项基于人群的研究。
Chin Med J (Engl). 2022 Jun 5;135(11):1369-1375. doi: 10.1097/CM9.0000000000002172.
2
A neglected cause for chronic spontaneous urticaria in children: Helicobacter pylori.儿童慢性自发性荨麻疹的一个被忽视的病因:幽门螺杆菌。
Allergol Immunopathol (Madr). 2015 May-Jun;43(3):259-63. doi: 10.1016/j.aller.2013.12.001. Epub 2014 Mar 20.
3
[Pathogenic and clinical significance of Helicobacter pylori infection in chronic urticaria and angioedema].幽门螺杆菌感染在慢性荨麻疹和血管性水肿中的致病及临床意义
Pol Merkur Lekarski. 2004 Oct;17(100):399-402.
4
[Prevalence and potential triggering factors of chronic urticaria and angioedema in an urban area of northeastern Mexico].[墨西哥东北部城市地区慢性荨麻疹和血管性水肿的患病率及潜在触发因素]
Rev Alerg Mex. 2004 Sep-Oct;51(5):181-8.
5
[Presence of anti-Helicobacter pylori, antithyroid, and high-affinity IgE receptor antibodies in patients with chronic urticaria].[慢性荨麻疹患者中抗幽门螺杆菌、抗甲状腺及高亲和力IgE受体抗体的存在情况]
Rev Alerg Mex. 2003 May-Jun;50(3):96-102.
6
Is Helicobacter pylori infection associated with chronic idiopathic urticaria?幽门螺杆菌感染与慢性特发性荨麻疹有关吗?
Allergol Immunopathol (Madr). 2003 Jul-Aug;31(4):209-14. doi: 10.1016/s0301-0546(03)79180-0.
7
Clinicoepidemiologic Features of Chronic Urticaria in Patients with versus without Subclinical Helicobacter pylori Infection: A Cross-Sectional Study of 150 Patients.合并与未合并亚临床幽门螺杆菌感染的慢性荨麻疹患者的临床流行病学特征:一项针对150例患者的横断面研究
Int Arch Allergy Immunol. 2018;175(1-2):114-120. doi: 10.1159/000485893. Epub 2018 Jan 19.
8
Is Helicobacter pylori infection associated with chronic urticaria?幽门螺杆菌感染与慢性荨麻疹有关吗?
Acta Derm Venereol. 2000 Nov-Dec;80(6):425-6. doi: 10.1080/000155500300012837.
9
Chronic idiophatic urticaria and Helicobacter pylori: a specific pattern of gastritis and urticaria remission after Helicobacter pylori eradication.慢性特发性荨麻疹与幽门螺杆菌:幽门螺杆菌根除后胃炎和荨麻疹缓解的特定模式。
Int J Immunopathol Pharmacol. 2012 Jul-Sep;25(3):765-70. doi: 10.1177/039463201202500324.
10
Chronic urticaria in Chinese population: a hospital-based multicenter epidemiological study.中国人群慢性荨麻疹:一项基于医院的多中心流行病学研究。
Allergy. 2014 Mar;69(3):359-64. doi: 10.1111/all.12338. Epub 2013 Dec 20.

引用本文的文献

1
Burden of and Trends in urticaria from 1990 to 2021 in China: A time-trend analysis and comparison with the United States and United Kingdom based on the GBD 2021.1990年至2021年中国荨麻疹的负担及趋势:基于全球疾病负担研究(GBD)2021的时间趋势分析以及与美国和英国的比较
PLoS One. 2025 Aug 29;20(8):e0330866. doi: 10.1371/journal.pone.0330866. eCollection 2025.
2
Global, regional, and National burden of urticaria (1990-2021), its potential risk factors, and projections to 2046.1990-2021年全球、区域和国家荨麻疹负担、潜在风险因素及到2046年的预测
BMC Public Health. 2025 Aug 8;25(1):2709. doi: 10.1186/s12889-025-23321-y.
3
Clinical profile, prevalence, and burden of chronic spontaneous urticaria in the United States.
美国慢性自发性荨麻疹的临床特征、患病率及负担
World Allergy Organ J. 2025 Jul 18;18(8):101081. doi: 10.1016/j.waojou.2025.101081. eCollection 2025 Aug.
4
Clinical efficacy and safety of acupuncture in the treatment for chronic spontaneous urticaria: a systematic review and meta-analysis.针刺治疗慢性自发性荨麻疹的临床疗效与安全性:一项系统评价与Meta分析
Front Med (Lausanne). 2025 May 30;12:1498795. doi: 10.3389/fmed.2025.1498795. eCollection 2025.
5
Equivalence of SYN008 versus omalizumab in patients with refractory chronic spontaneous urticaria: A multicenter, randomized, double-blind, parallel-group, active-controlled phase III study.SYN008与奥马珠单抗治疗难治性慢性自发性荨麻疹患者的等效性:一项多中心、随机、双盲、平行组、活性药物对照的III期研究。
Chin Med J (Engl). 2025 Aug 20;138(16):2040-2042. doi: 10.1097/CM9.0000000000003593. Epub 2025 Jun 6.
6
Incidence and Prevalence of Chronic Spontaneous Urticaria Among Adult and Pediatric Populations in the United States.美国成人和儿童人群中慢性自发性荨麻疹的发病率和患病率
Adv Ther. 2025 Jun;42(6):2808-2820. doi: 10.1007/s12325-025-03172-0. Epub 2025 Apr 16.
7
Changes in Clinical Trials of Dermatological Drugs in Mainland China Between 2016 and 2022: A Narrative Review.2016年至2022年中国大陆皮肤病药物临床试验的变化:一项叙述性综述
Ther Innov Regul Sci. 2025 May;59(3):450-461. doi: 10.1007/s43441-025-00743-9. Epub 2025 Feb 13.
8
Prioritising patient-centred care in the management of chronic urticaria in Asia-Pacific countries.在亚太国家慢性荨麻疹管理中优先考虑以患者为中心的护理。
World Allergy Organ J. 2024 Oct 31;17(11):100984. doi: 10.1016/j.waojou.2024.100984. eCollection 2024 Nov.
9
Beyond the classic players: Mas-related G protein-coupled receptor member X2 role in pruritus and skin diseases.超越经典参与者:Mas相关G蛋白偶联受体成员X2在瘙痒和皮肤病中的作用
J Eur Acad Dermatol Venereol. 2025 Mar;39(3):476-486. doi: 10.1111/jdv.20249. Epub 2024 Jul 23.
10
Efficacy, safety, and serum cytokine modulation by olopatadine hydrochloride and desloratadine citrate disodium combination therapy in urticaria.盐酸奥洛他定与枸橼酸地氯雷他定二钠联合治疗荨麻疹的疗效、安全性及对血清细胞因子的调节作用
Am J Transl Res. 2024 Jun 15;16(6):2501-2508. doi: 10.62347/XMFX3074. eCollection 2024.